Concepedia

Author

Jean Latreille

Hôpital Charles-Le Moyne

Also Known As

C Bertrand, J Latreille, J. Latreille, J. M. Latreille, Jean Latreille, S. Dent

130

Publications

5K

Citations

36

H-Index

90

Concepts

All Affiliations

Hôpital Charles-Le MoyneBC Cancer AgencyHôtel-Dieu de MontréalUniversité de SherbrookeOntario Institute for Cancer Research
JL

About

Jean Latreille is an author at Hôpital Charles-Le Moyne specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

37

2.2K

2

Health Sciences

9

9

363

3

Nursing

1

1

411

4

Public Health

1

1

18

5

Allergy

1

1

16

Jean Latreille

×

61

Publications

4.3K

Citations

34

H-Index

YearCitations

Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer

David Osoba, Benny Zee, Joseph L. Pater,

Quality of Life Research

1994

411

Cellular DNA content as a marker of neoplasia in man

Barthel Barlogie, Benjamin Drewinko, J. Schumann,

The American Journal of Medicine

1980

300

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

Pierfranco Conté, Jean Latreille, L. Mauriac,

Journal of Clinical Oncology

1996

268

Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation

Béatrice Fervers, Jako Burgers, Rachel Voellinger,

BMJ Quality & Safety

2011

250

Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.

David Osoba, Benny Zee, Joseph L. Pater,

Journal of Clinical Oncology

1997

215

Effect of postchemotherapy nausea and vomiting on health-related quality of life

David Osoba, Benny Zee, David Warr,

Supportive Care in Cancer

1997

204

Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women

Nicole H�bert-croteau, Jacques Brisson, Jean Latreille,

Cancer

1999

190

Compliance With Consensus Recommendations for Systemic Therapy Is Associated With Improved Survival of Women With Node-Negative Breast Cancer

Nicole Hébert‐Croteau, Jacques Brisson, Jean Latreille,

Journal of Clinical Oncology

2004

169

Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8

B. Norris, Kathleen I. Pritchard, K. James,

Journal of Clinical Oncology

2000

143

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

Christophe Tournigand, Benoist Chibaudel, Benoît Samson,

The Lancet Oncology

2015

120

Page 1